secwatch.observer — SEC 8-K summary
======================================

Issuer:     Arcellx, Inc. (ACLX)
CIK:        0001786205
Form:       8-K
Filed at:   2023-12-28T23:59:59+00:00
Accession:  0001193125-23-305194
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Arcellx closes $200M Gilead investment and license amendment with Kite
----------------------------------------------------------------------

- Closed transactions: issued 3,242,542 shares to Gilead for $200 million aggregate.
- Includes amendment to Collaboration and License Agreement with Kite Pharma (Gilead).
- Closing followed expiration of HSR waiting period under antitrust rules.
- Shares issued on December 28, 2023; previously announced November 15, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1786205/000119312523305194/0001193125-23-305194-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1786205/000119312523305194/d607811d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-305194

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer